Technical Analysis for BXN - Bioxyne Ltd  

Grade Last Price % Change Price Change
C 0.012 0.00% 0.000
BXN closed unchanged on Friday, November 1, 2024, on 1.33 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Nov 15
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -7.69%
Wide Bands Range Expansion -7.69%
Crossed Above 20 DMA Bullish -7.69%

   Recent Intraday Alerts

Alert Time
5x Volume Pace 2 days ago
3x Volume Pace 2 days ago
2x Volume Pace 2 days ago
1.5x Volume Pace 2 days ago
Rose Above 50 DMA 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It focuses on immune health and immunotherapeutic products. The Company's focus is on its probiotic business and product Lactobacillus fermentum PCC. The Company holds an interest in Mariposa Health Limited, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Pharmaceutical Development Probiotic Bio Technology Digestive System Immunotherapeutic Products

Is BXN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.021
52 Week Low 0.004
Average Volume 2,802,937
200-Day Moving Average 0.010
50-Day Moving Average 0.012
20-Day Moving Average 0.012
10-Day Moving Average 0.013
Average True Range 0.001
RSI (14) 50.00
ADX 26.61
+DI 26.543
-DI 20.370
Chandelier Exit (Long, 3 ATRs) 0.010
Chandelier Exit (Short, 3 ATRs) 0.013
Upper Bollinger Bands 0.015
Lower Bollinger Band 0.009
Percent B (%b) 0.52
BandWidth 45.378
MACD Line 0.000
MACD Signal Line 0.000
MACD Histogram 0.0
Fundamentals Value
Market Cap 7.68 Million
Num Shares 640 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio -6.00
Price-to-Sales 3.40
Price-to-Book 3.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.012
Resistance 3 (R3) 0.012 0.012 0.012
Resistance 2 (R2) 0.012 0.012 0.012 0.012
Resistance 1 (R1) 0.012 0.012 0.012 0.012 0.012
Pivot Point 0.012 0.012 0.012 0.012 0.012
Support 1 (S1) 0.012 0.012 0.012 0.012 0.012
Support 2 (S2) 0.012 0.012 0.012 0.012
Support 3 (S3) 0.012 0.012 0.012
Support 4 (S4) 0.012